These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 12503526)
21. Simulation of roller compaction by combination of a compaction simulator and oscillating mill - A material sparing approach. Hassan L; Jensen R; Megarry A; Blaabjerg LI Int J Pharm; 2023 Sep; 644():123281. PubMed ID: 37524254 [TBL] [Abstract][Full Text] [Related]
22. Functionality of magnesium stearate derived from bovine and vegetable sources: dry granulated tablets. Hamad ML; Gupta A; Shah RB; Lyon RC; Sayeed VA; Khan MA J Pharm Sci; 2008 Dec; 97(12):5328-40. PubMed ID: 18351597 [TBL] [Abstract][Full Text] [Related]
23. Determination of total hypericins in St. John's wort and herbal medicinal products. Anyzewska M; Kowalczuk A; Łozak A; Jabłczyńska R; Fijałek Z Acta Pol Pharm; 2010; 67(6):586-92. PubMed ID: 21229872 [TBL] [Abstract][Full Text] [Related]
24. Combining experimental design and orthogonal projections to latent structures to study the influence of microcrystalline cellulose properties on roll compaction. Dumarey M; Wikström H; Fransson M; Sparén A; Tajarobi P; Josefson M; Trygg J Int J Pharm; 2011 Sep; 416(1):110-9. PubMed ID: 21708239 [TBL] [Abstract][Full Text] [Related]
25. Roller compaction process development and scale up using Johanson model calibrated with instrumented roll data. Nesarikar VV; Patel C; Early W; Vatsaraj N; Sprockel O; Jerzweski R Int J Pharm; 2012 Oct; 436(1-2):486-507. PubMed ID: 22721851 [TBL] [Abstract][Full Text] [Related]
26. Improving the hardness of dry granulated tablets containing sodium lauryl sulfate. Moore F; Okelo G; Colón I; Kushner J Int J Pharm; 2010 Nov; 400(1-2):37-41. PubMed ID: 20801204 [TBL] [Abstract][Full Text] [Related]
27. A comparative study of the influence of alpha-lactose monohydrate particle morphology on granule and tablet properties after roll compaction/dry granulation. Grote S; Kleinebudde P Pharm Dev Technol; 2019 Mar; 24(3):314-322. PubMed ID: 29757067 [TBL] [Abstract][Full Text] [Related]
28. The effect of excipient particle size on the reduction of compactibility after roller compaction. Janssen PHM; Jaspers M; Meier R; Roelofs TP; Dickhoff BHJ Int J Pharm X; 2022 Dec; 4():100117. PubMed ID: 35496756 [TBL] [Abstract][Full Text] [Related]
29. Roller compaction of crude plant material: influence of process variables, polyvinylpyrrolidone, and co-milling. Heng PW; Chan LW; Liew CV; Chee SN; Soh JL; Ooi SM Pharm Dev Technol; 2004; 9(2):135-44. PubMed ID: 15202572 [TBL] [Abstract][Full Text] [Related]
30. Near-infrared chemical imaging (NIR-CI) as a process monitoring solution for a production line of roll compaction and tableting. Khorasani M; Amigo JM; Sun CC; Bertelsen P; Rantanen J Eur J Pharm Biopharm; 2015 Jun; 93():293-302. PubMed ID: 25917640 [TBL] [Abstract][Full Text] [Related]
31. Insensitivity of compaction properties of brittle granules to size enlargement by roller compaction. Wu SJ; Sun C J Pharm Sci; 2007 May; 96(5):1445-50. PubMed ID: 17455348 [TBL] [Abstract][Full Text] [Related]
32. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content. Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879 [TBL] [Abstract][Full Text] [Related]
33. Eudragit(®) RS PO/RL PO as rate-controlling matrix-formers via roller compaction: Influence of formulation and process variables on functional attributes of granules and tablets. Dave VS; Fahmy RM; Bensley D; Hoag SW Drug Dev Ind Pharm; 2012 Oct; 38(10):1240-53. PubMed ID: 22257339 [TBL] [Abstract][Full Text] [Related]
34. A study of the compaction process and the properties of tablets made of a new co-processed starch excipient. Mužíková J; Eimerová I Drug Dev Ind Pharm; 2011 May; 37(5):576-82. PubMed ID: 21469946 [TBL] [Abstract][Full Text] [Related]
35. The relevance of granule fragmentation on reduced tabletability of granules from ductile or brittle materials produced by roll compaction/dry granulation. Skelbæk-Pedersen AL; Vilhelmsen TK; Rantanen J; Kleinebudde P Int J Pharm; 2021 Jan; 592():120035. PubMed ID: 33152477 [TBL] [Abstract][Full Text] [Related]
36. Improving the compaction properties of roller compacted calcium carbonate. Bacher C; Olsen PM; Bertelsen P; Kristensen J; Sonnergaard JM Int J Pharm; 2007 Sep; 342(1-2):115-23. PubMed ID: 17582712 [TBL] [Abstract][Full Text] [Related]
37. Determining the Impact of Roller Compaction Processing Conditions on Granule and API Properties. Clarke J; Gamble JF; Jones JW; Tobyn M; Dawson N; Davies C; Ingram A; Greenwood R AAPS PharmSciTech; 2020 Aug; 21(6):218. PubMed ID: 32743765 [TBL] [Abstract][Full Text] [Related]
38. Unified compaction curve model for tensile strength of tablets made by roller compaction and direct compression. Farber L; Hapgood KP; Michaels JN; Fu XY; Meyer R; Johnson MA; Li F Int J Pharm; 2008 Jan; 346(1-2):17-24. PubMed ID: 17689211 [TBL] [Abstract][Full Text] [Related]
39. Excipient-process interactions and their impact on tablet compaction and film coating. Pandey P; Bindra DS; Gour S; Trinh J; Buckley D; Badawy S J Pharm Sci; 2014 Nov; 103(11):3666-3674. PubMed ID: 25223603 [TBL] [Abstract][Full Text] [Related]
40. Roll compaction/dry granulation: effect of raw material particle size on granule and tablet properties. Herting MG; Kleinebudde P Int J Pharm; 2007 Jun; 338(1-2):110-8. PubMed ID: 17324537 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]